Skip to main content
. 2021 Feb 10;19:9. doi: 10.1186/s12959-021-00261-2

Table 2.

VTE prophylaxis/treatment of the included patients

Variables Patients (N = 704)
No. of patients received prophylaxis, No. (%) 415 (58.9)
 - Pharmacological anticoagulant prophylaxis 371 (52.7)
 - Mechanical prophylaxis 13 (1.8)
 - Pharmacological and Mechanical prophylaxis 31 (4.4)
Types of anticoagulant, No. (%)
 - LMWH 366 (51.9)
 - Unfractionated Heparin 56 (7.9)
Timing of anticoagulants for surgical patients, No. (%)
 - Preoperatively 138 (59.23)
 - Postoperatively 94 (40.34)
 - Preoperatively/ Postoperatively 1 (0.43)
No. of patients continued prophylaxis after discharge, No. (%) 128 (30.84)
Duration of LMWH after discharge, mean (SD) 17.58 (80.9)
Duration of Warfarin after discharge, mean (SD) 28 (16.2)
Concomitant treatment No. (%) 460 (65.34)

LMWH Low molecular weight heparin, SD Standard deviation